Brian Finrow
@Finrow
Followers
342
Following
164
Media
21
Statuses
406
Founder/CEO at Lumen Bio. I'm a quasi-outsider to the biopharma industry, interested in the economics of drug development.
Seattle, Washington USA
Joined August 2009
Uncommon results like this are commonplace at Lumen Bio. Requires a team with uncommon talent — talented people like YOU!. Join us! Especially — right now — if you have a passion for clinical trials or assay qualification/validation.
Promising news for C. diff patients! 100% of patients with LMN-201 + antibiotics successfully resolved their primary infection, and 95% of participants had no recurrence within 28 days (RePreve Trial sentinel cohort results). #PatientCare #Clinicaltrial
1
0
4
RT @RuxandraTeslo: Advice on regulation gets dispensed by CDMOs and regulatory consultants whose earnings and prestige are highly correlate….
0
1
0
RT @RuxandraTeslo: .@tylercowen said that he watches flows of people to get a feel for things he doesn't understand fully. I don't know evt….
0
1
0
RT @RuxandraTeslo: Neither RFK, nor the FDA can release regulatory filings, no matter how much they loved transparency, due to trade secret….
0
2
0
RT @RuxandraTeslo: Idea sparked by an article in @statnews from @Finrow. Also benefitted from legal advice and support from the @IFP team,….
0
1
0
RT @incredutility: This seems like something @patrickc should do. One of a handful of people who could easily be more ambitious with their….
0
2
0
RT @KumarAGarg: I like this idea - targeting the capture of IP at time of bankruptcy is a promising and under-leveraged use of philanthropi….
0
3
0
RT @RuxandraTeslo: AI holds immense promise in speeding up the regulatory process that biotech companies have to go through. But it can onl….
0
1
0
RT @JacobTref: Still slowly making my way through the many science policy articles just dropped by @IFP. Enjoying this piece by @RuxandraTe….
0
7
0
RT @AlecStapp: 7. @RuxandraTeslo on how to turn the FDA’s data archive into faster clinical trials:
ifp.org
How to fuel AI by unlocking the FDA’s knowledge of biotech failures
0
5
0
RT @RuxandraTeslo: The FDA is sitting on a goldmine of drug development data — 10,000+ page dossiers detailing how drugs are designed, made….
ifp.org
How to fuel AI by unlocking the FDA’s knowledge of biotech failures
0
125
0
RT @_rossry: @incredutility Oh phew, I thought I was the only one kicking myself over missing the idea.
0
1
0
RT @incredutility: This is great. I invest in biotech companies and this has never occurred to me!.
0
7
0
.@_rossry doesn't ask easy questions—he asks the right ones. Honored to be an early guest on the new @DevAndResearch interview series, where we dug deep on what makes drug development tick.
We're back with @DevAndResearch, where I spoke with @Finrow on:.��� why we should grow more drugs in algae, and fewer in Chinese Hamster Ovary cells,.• why "monoclonal antibodies" are particularly safe and effective as drugs—but incredibly expensive to manufacture,.• and whether
0
4
10
FDA has one such huge data repository, currently locked away and sitting idle. Perhaps easily unlockable albeit with some agency creativity—idea #4 in this piece by me and @innovationwonk in @statnews last week:.
Concur. We habitually undersample (yes a part is driven by historical data acquisition challenges but those are mostly obsolete now). We also don’t SHARE data - yes I welcome people yelling at me “but we do” <- we don’t and everyone knows it!. We need giant repositories of all.
0
3
9
Good or bad, when institutions are remade it's an opportunity for fresh new ideas to root. There's plenty of negative criticism out there—from all sides—but @innovationwonk and I jotted down some constructive ideas to throw into the mix—published here in @statnews
3
3
9
RT @cremieuxrecueil: There is an insane degree of crowding out in pharma research. Everyone and their mother seems to be focusing on the s….
0
16
0